Position statements

It is necessary for ASBMB to have standing positions on issues germane to the scientific community. The Public Affairs Advisory Committee works to draft position statements that are approved by the ASBMB Council.

• The ASBMB supports the Women and Minorities in STEM Booster Act
  July 15, 2021
• ASBMB statement on how racial profiling hurts science
  June 29, 2021
• ASBMB statement on President Joe Biden's fiscal 2022 budget request
  April 12, 2021
• The ASBMB supports the MSI STEM Achievement Act
  April 12, 2021
• The ASBMB urges the passage of the RISE Act
  February 9, 2021
• The ASBMB calls for targeted COVID-19 relief for junior scientists
  February 9, 2021
• The ASBMB supports amnesty for academics to disclose foreign funding
  February 1, 2021
• The ASBMB applauds Biden's memo on restoring scientific integrity in the federal government
  January 29, 2021
• ASBMB statement on the importance of international collaboration in STEM
  January 20, 2021
• ASBMB statement on the STEM Opportunitites Act
  January 19, 2021
• ASBMB statement on President-elect Joseph Biden's announced science team
  January 15, 2021
• ASBMB statement on the Supporting Early-Career Researchers Act
  January 12, 2021
• ASBMB statement on the importance of science and evidence-based policymaking
  December 7, 2020
• ASBMB statement on fiscal year 2021 spending proposal
  November 10, 2020
• ASBMB statement on Trump's executive order creating schedule F in the excepted service
  November 3, 2020
• The ASBMB responds to Trump administration's proposed restrictions on student and scientist visas
  October 26, 2020
• ASBMB statement on Trump's executive order banning racial sensitivity training for federal contractors
  September 25, 2020
• The ASBMB endorses the STEM RESTART Act
  September 24, 2020
• The ASBMB denounces statements made by Assistant Secretary Michael Caputo
  September 14, 2020
• The ASBMB signs on United States v. Tao amicus brief
  August 25, 2020
• ASBMB statement on FDA emergency use reauthorization of blood plasma therapy for COVID-19 patients
  August 23, 2020
• The ASBMB rejects President Donald Trump's accusations against scientists
  August 20, 2020
• ASBMB statement on the RISE Act
  August 11, 2020
• ASBMB statement on Safeguarding American Innovation Act
  July 21, 2020
• ASBMB statement on modifications to the Student and Exchange Visitor Program
  July 7, 2020
• ASBMB statement on presidential proclamation restricting foreign worker visas
  June 23, 2020
• ASBMB statement on the Supreme Court's decision to uphold DACA
  June 18, 2020
• ASBMB statement on canceling student visas for Chinese students
  June 1, 2020
• ASBMB statement on SECURE CAMPUS Act
  May 28, 2020
• ASBMB Supporting the Independence of Science sign on letter
  May 20, 2020
• ASBMB statement on HEROES Act
  May 13, 2020
• ASBMB statement on revocation of EcoHealth Alliance grant on bat–human virus transmission
  April 28, 2020
• ASBMB statement on U.S. Sen. Tom Cotton's remarks on Chinese students in the U.S.
  April 27, 2020
• ASBMB statement following President Donald Trump’s suspension of immigration
  April 23, 2020
• ASBMB statement on reassignment of BARDA Director Dr. Rick Bright
  April 22, 2020
• ASBMB statement responding to President Trump's comments on National Institutes of Health funding
  April 19, 2020
• ASBMB statement on Foreign Influences to Research Integrity
  April 6, 2020
• ASBMB statement on COVID-19 stimulus package
  March 25, 2020
• ASBMB statement on President Donald Trump’s budget request for Fiscal Year 2021
  Feb. 10, 2020
• ASBMB statement on President Donald Trump’s State of the Union address
  Feb. 5, 2020
• ASBMB Statement on President Trump's National Address
• ASBMB Statement on NIH efforts to address sexual harassment
• ASBMB Statement on the appointment of Kelvin Droegemeier
• ASBMB statement on FY19 budget proposal
• ASBMB statement on passage of 2018 budget deal
• ASBMB statement on the 2018 state of the union address
• ASBMB statement on 2018 government shutdown
• ASBMB statement in response to H.R. 1, the tax cuts and jobs act
• ASBMB statement on Trump’s decision to end DACA 
• ASBMB responds to Congress passing FY17 appropriations 
• ASBMB statement supporting peer-reviewed science at federal agencies 
• ASBMB statement on President Donald J. Trump’s executive order restricting immigration 
• ASBMB statement regarding the use of preprints in NIH grant review 
• ASBMB responds to Trump budget proposal that threatens funding for 2,000 research projects 
• ASBMB statement on President Donald Trump’s FY2018 Budget Proposal 
• ASBMB statement on its commitment to diversity and inclusion upon the election of Donald Trump as president of the United States
• ASBMB responds to President Donald Trump's fiscal year 2018 budget
• ASBMB Statement on 21st Century Cures Act
• ASBMB Position Statement on Human Embryonic Stem Cells
• ASBMB White Paper on Proposals to Support Investigator-Initiated Research
• ASBMB Position Statement on the Peer-Review Process
• ASBMB responds to the Supreme Court ruling on gene patents
• ASBMB white paper on building a Sustainable Biomedical Research Enterprise
• ASBMB statement opposing the Research for Lifesaving Cures Act
• ASBMB statement opposing the Frontiers in Innovation, Research, Science and Technology Act
• ASBMB comments on the 21st Century Cures Discussion Draft
• ASBMB responds to the NIH's request for information on a proposed emeritus award for senior investigators
• ASBMB responds to the NIH's request for information on the Science Education Partnership Award program
• ASBMB responds to the Department of Labor's proposed overtime rule change